tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics (IOVA)
NASDAQ:IOVA

Iovance Biotherapeutics (IOVA) Revenue

Compare
4,035 Followers

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had a revenue of 86.77M in the quarter ending Dec 31, 2025, with 28.64%. This bring the company's revenue in the last twelve months to 263.50M, Decreased 5.22%. In the fiscal year ending Dec 31, 2025, Iovance Biotherapeutics had annual revenue of 263.50M with 60.60% growth.
Revenue (ttm)
263.50M
Revenue Growth
175.62%
P/S Ratio
6.05
Revenue/Employee
$314,442
Employees
838
Market Cap
$1.59B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
263.50M99.43M+60.60%
Dec 31, 2024
164.07M162.88M+13,698.99%
Dec 31, 2023
1.19M+∞%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017